Navigation Links
NewCardio Announces Master Services Agreement With Dedicated Phase I
Date:8/5/2009

his agreement demonstrates the firm's commitment to the use of technology to improve quality and efficiency."

This Master Services Agreement is part of a transition from semi-automated methods to more advanced, higher quality, and more efficient methodologies made possible for the first time through the use of NewCardio's QTinno(TM) solution.

NewCardio's innovative 3D ECG platform technology dramatically improves the accuracy and significantly increases the diagnostic value of the standard 12-lead electrocardiogram (ECG). NewCardio's lead product is QTinno(TM), a software suite that provides an automated, comprehensive analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug regulators. The Company believes that its QTinno(TM), software-based, analytical technology is the industry's first solution for the reliable automated analysis of ECGs used to determine cardiac toxicity during drug development.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

Forward-Looking Statements

This press rele
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewCardio Leadership to Present Two Abstracts at ISCE Conference
2. Vincent W. Renz Joins NewCardio as President
3. NewCardio Announces Positive Results From Third Clinical Validation Study
4. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
5. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
6. Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
7. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
8. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
9. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
10. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
11. AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 3, ... therapeutics for the treatment of cancer, today announced ... team. Debanjan Ray , who ... and alliance management, has been promoted to senior ... to joining CytomX, Mr. Ray held positions as ...
(Date:8/3/2015)... PARK, N.J. , Aug. 3, 2015 ... and secondary endpoints in a phase III study (COMPOSE ... adult patients with chronic non-cancer pain. Naldemedine is an ... is the third Phase III trial in which naldemedine ... Study results showed that a 0.2 mg tablet of ...
(Date:8/3/2015)... Aug. 3, 2015  Encision Inc. (PK:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... ended June 30, 2015. The Company posted ... net loss of $213 thousand, or $(0.02) per share. ... for a net loss of $202 thousand, or $(0.02) ...
Breaking Medicine Technology:CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5
... Inc. (NYSE: LDR), will release financial results for the ... December 6, 2011. The company will host ... at 2:00 p.m. Eastern Time. Investors may access the live ... or 480-629-9692 (international callers), or by visiting the "Investors" page ...
... Nov. 22, 2011  Colorado Drug Card, in partnership with ... has agreed to be the "Preferred Pharmacy" for the ... to process prescriptions through Colorado Drug Card. Coloradans can ... pharmacist to process their prescription through the Colorado Drug ...
Cached Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2011 Results 2
(Date:8/3/2015)... , ... August 03, 2015 , ... Representatives with ... service on its website. , “Our ‘Ask a Nutritionist’ feature on our website is ... eat healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health ...
(Date:8/3/2015)... ... , ... The Workgroup for Electronic Data Interchange ( WEDI ), the nation’s ... information exchange, announced the release of its findings from its June 2015 ICD-10 Industry ... shared survey results and recommendations , strongly encouraging the department to ...
(Date:8/3/2015)... ... , ... They know every second counts. And when it comes to stroke, ... the best care in the nation. For the past two months, the stroke team ... removal time in the country. During the months of June and July, it took ...
(Date:8/3/2015)... ... August 03, 2015 , ... BESLER Consulting ... Bulb B2B Awards. , The MarketingProfs Bright Bulb B2B Awards celebrate the best ... campaign for the launch of their Readmissions Analytics product was selected as one ...
(Date:8/3/2015)... ... 2015 , ... Novation, the nation’s largest healthcare services organization, ... and precision medicine solutions that can help pharmacists and other healthcare providers improve ... million adverse drug events are reported in the U.S. Pharmacogenetic testing allows ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3
... A new study has found that 27% of Medicare Advantage and ... and possibly switch their Medicare coverage. The figure is up ... "intention to switch" measure has been a leading indicator of actual ... switch actually will leave their current insurer for another, this year,s ...
... progression and reduce expenses, researchers say , MONDAY, Nov. ... in the United States costs $185.5 billion a year, ... insurers pay $149.4 billion while patients pay $36.1 billion ... female patient and $4,036 per male patient. Women also ...
... later in life, , MONDAY, Nov. 30 (HealthDay News) -- ... being born with Down syndrome, federal researchers say. , The ... having babies. , Data from 10 regional registries of birth ... children increased by 31 percent between 1979 and 2003, from ...
... Finding and treating a tumor without disturbing normal tissue presents ... and harsh. Researchers at Duke University Medical Center have ... to tumors using special molecules, called aptamers, which specifically bind ... of aptamers in a rodent with liver cancer until they ...
... ... service that lets users log into their Home or Office PC; from anywhere. This is ... Result, blazing fast performance even over slower connections. , ... Santa Clara, CA (PRWEB) November 30, 2009 -- ShowMyPC has released ...
... ... caregivers, and our community, ALL campuses affiliated with the Institute of Women,s Health of North ... individuals (male and female) 4 years and older. Please visit our website to locate a ... ...
Cached Medicine News:Health News:More Seniors Considering Health Insurance Switch 2Health News:Osteoarthritis Costs U.S. Over $185 Billion a Year 2Health News:U.S. Records Increase in Kids With Down Syndrome 2Health News:U.S. Records Increase in Kids With Down Syndrome 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3Health News:ShowMyPC Provides First Online Service in the World to Access Personal Computers from Anywhere Using Microsoft Remote Desktop 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 2Health News:2009 H1N1 Influenza Vaccination Being Offered at Various Affiliated Campuses of the Institute of Women's Health of North America in Florida 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: